Answer in brief
CVE-2026-118789 records a High severity (CVSS 8.1) vulnerability in Untrusted SQL Execution via HTTP-Delivered CIP News in Farmasimplex. The current sources do not mark it as known exploited. The current feed maps CIPCarbone/Farmasimplex (generic). Check affected ranges and fixed versions before updating.
Analysis pending evidence review
HOL Guard separates source facts from reviewed analysis. See the methodology.
CVSS is 8.1. The current sources do not mark it as known exploited. Treat this as a source-backed prioritization signal, not a statement about your environment.
Analysis status
Analysis pending evidence review
Factual feed record only; HOL analysis is not approved for indexing. Read the methodology.
The current feed maps CIPCarbone/Farmasimplex (generic). Check affected ranges and fixed versions before updating.
| Package | Affected range | Fixed version |
|---|---|---|
| CIPCarbone/Farmasimplexgeneric | >=0 <16.2.0 | 16.2.0 |
Published upstream
Nov 17, 2026
Evidence: source:cvelist:source_dates:source-dates:recordSource modified
Nov 17, 2026
Evidence: source:cvelist:source_dates:source-dates:recordFirst seen by HOL
Nov 17, 2026
Farmasimplex retrieves a CIP News file over HTTP and executes embedded SQL statements against the local FarmaCIP database with administrative privileges. An attacker able to tamper with network communications or compromise vendor infrastructure can inject arbitrary SQL commands, leading to unauthorized access to, modification or deletion of database contents and potentially operating system command execution.
Quoted source text, attributed separately from HOL analysis.